KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases

Rheumatology International

Volumn 19, Issue 6, 2000, Pages 223-225

  Fukaya, S ^a   Oshima, H ^a   Kato, K ^a   Komatsu, Y ^a   Matsumura, H ^a   Ishii, K ^a   Miyama, H ^a   Nagai, T ^a   Tanaka, I ^a   Mizutani, A ^a   Katayama, M ^a   Yoshida, S ^a   Torikai, K ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroids; Interstitial pneumonia; KL 6; Marker

Indexed keywords

GLYCOPROTEIN;

ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0033771886     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002960000064     Document Type: Article

References (9)

1. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases
2. Tacrolimus in refractory polymyositis with interstitial lung disease
3. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies. KL-3 and KL-6, against lung adenocartinoma
4. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia
5. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
6. A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis
7. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
8. The 1982 revised criteria for the classification of systemic lupus erythematosus
9. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin